Close
ACHEMA MIDDLE EAST 2026

Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came...

Chinese Market Regulator Fines Two Monopolistic Pharma Firms

Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million...

Enhancing Patient Care In The UK Through Recognition Routes

The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established...

EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

The European Medicines Agency (EMA) has initiated a review of medications containing hydroxyprogesterone due to concerns regarding their safety and efficacy. These medications, known...

WHO Utilizes Pathogen Genomics For Global Disease Protection

World Health Organization, partners are going ahead with the launch of a global network that will help protect people from infectious disease threats by...

Key Areas For AI/ML Drug Development – FDA Discussion Paper

A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine...

ABPI and NHS Are in Talks for New Medicines Scheme in the UK

The government of the UK, NHS England, as well as the Association of the British Pharmaceutical Industry have gone on to open new negotiations...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...